96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. - Farrell, Michael; Shahbazi, Jeyran; Chambers, Mark; Byrne, Marianne; Gholami, Jaleh; Zahra, Emma; Grebely, Jason; Lintzeris, Nicholas; Larance, Briony; Ali, Robert; Nielsen, Suzanne; Dunlop, Adrian; et al. (International Journal of Drug Policy, 2024)